IRIS UniCatt

Petito, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.874
AS - Asia 3.082
EU - Europa 2.952
SA - Sud America 618
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 7
Totale 10.613
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.727
SG - Singapore 1.396
CN - Cina 760
IT - Italia 702
DE - Germania 630
BR - Brasile 510
SE - Svezia 437
FR - Francia 279
VN - Vietnam 255
PL - Polonia 195
GB - Regno Unito 154
IN - India 110
UA - Ucraina 109
IE - Irlanda 108
FI - Finlandia 101
HK - Hong Kong 90
ID - Indonesia 89
JP - Giappone 76
CA - Canada 69
TR - Turchia 68
RU - Federazione Russa 61
BD - Bangladesh 44
AR - Argentina 42
MX - Messico 42
KR - Corea 36
BE - Belgio 35
NL - Olanda 35
ES - Italia 26
ZA - Sudafrica 24
IQ - Iraq 22
IR - Iran 20
EC - Ecuador 17
CO - Colombia 12
PK - Pakistan 12
VE - Venezuela 12
AT - Austria 11
CH - Svizzera 11
EU - Europa 11
EG - Egitto 10
SA - Arabia Saudita 10
AE - Emirati Arabi Uniti 9
NP - Nepal 9
TN - Tunisia 9
CZ - Repubblica Ceca 8
JM - Giamaica 8
AZ - Azerbaigian 7
CL - Cile 7
CR - Costa Rica 7
MA - Marocco 7
RO - Romania 7
UZ - Uzbekistan 7
IL - Israele 6
LT - Lituania 6
PE - Perù 6
PH - Filippine 6
PY - Paraguay 6
CI - Costa d'Avorio 5
HN - Honduras 5
TH - Thailandia 5
AU - Australia 4
BH - Bahrain 4
HU - Ungheria 4
JO - Giordania 4
KE - Kenya 4
KZ - Kazakistan 4
OM - Oman 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KH - Cambogia 3
LV - Lettonia 3
MY - Malesia 3
NI - Nicaragua 3
PT - Portogallo 3
TW - Taiwan 3
AO - Angola 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
KG - Kirghizistan 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
YE - Yemen 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
Totale 10.596
Salva come PNG Salva come JPEG
Città #
Singapore 811
Chandler 463
San Jose 410
Ashburn 395
Beijing 194
Warsaw 165
Los Angeles 127
Rome 124
New York 113
Dublin 108
Cattolica 107
Ho Chi Minh City 90
Jacksonville 83
Lauterbourg 79
Jakarta 78
Ann Arbor 77
Hong Kong 75
The Dalles 65
Munich 64
Tokyo 63
Frankfurt am Main 62
Hanoi 61
São Paulo 60
Hefei 58
Milan 57
San Mateo 55
Boston 54
Wilmington 52
Dallas 50
Nanjing 49
Helsinki 46
Hangzhou 43
Houston 43
Izmir 38
Woodbridge 38
Moscow 36
Princeton 36
Marseille 35
Boardman 34
Dearborn 34
Santa Clara 33
Chicago 31
Council Bluffs 31
Fairfield 31
London 30
Shanghai 30
North Bergen 29
Nuremberg 29
Brussels 27
Redwood City 27
Seattle 26
Nürnberg 25
Seoul 25
Brooklyn 23
Lawrence 23
Turku 23
Orem 21
Paris 21
Buffalo 20
Nanchang 18
Stockholm 18
Guangzhou 17
Kent 17
Kraków 17
Lancaster 17
Montreal 17
Rio de Janeiro 17
Shenyang 17
Toronto 17
Atlanta 16
Bremen 16
Da Nang 16
Redmond 16
St Louis 16
Chennai 15
Johannesburg 15
Mexico City 15
Phoenix 15
San Francisco 15
Amsterdam 14
Memphis 14
Mountain View 14
Denver 13
Naples 13
Tianjin 13
Zhengzhou 13
Augusta 12
Baghdad 12
Charlotte 12
Düsseldorf 12
Fremont 12
Haiphong 12
Poplar 12
Pune 12
Cambridge 11
Hyderabad 11
Kish 11
Manchester 11
Norwalk 11
Hebei 10
Totale 5.719
Salva come PNG Salva come JPEG
Nome #
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 373
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 234
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 230
Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease 215
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 210
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 210
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 209
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 199
13C-octanoic acid breath test to study gastric emptying time 185
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 182
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 175
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 175
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 166
Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives 163
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 162
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 161
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation 156
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 155
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 154
Tumor necrosis factor-α and solute carrier family 22 member 4 gene polymorphisms as potential determinants of intestinal dysbiosis 154
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 153
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 153
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 151
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 151
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 151
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 148
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 143
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 142
An Integrative Multi-omic Analysis defines Gut Microbiota, Mycobiota and Metabolic fingerprints in Ulcerative Colitis Patients 137
Dietary magnesium alleviates experimental murine colitis through modulation of gut microbiota 137
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 135
Characterization of the gut-liver-muscle axis in cirrhotic patients with sarcopenia 135
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma 133
Gut Microbiota: A Key Modulator of Intestinal Healing in Inflammatory Bowel Disease 132
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 131
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 130
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 129
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 129
Commensal Clostridia: leading players in the maintenance of gut homeostasis 128
Effect of a multistrain probiotic on leaky gut in patients with diarrhea-predominant irritable bowel syndrome (IBS-D): a pilot study 127
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 127
Ecology and Machine Learning-Based Classification Models of Gut Microbiota and Inflammatory Markers May Evaluate the Effects of Probiotic Supplementation in Patients Recently Recovered from COVID-19 126
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 125
Hepatocellular Carcinoma is Associated with Gut Microbiota Profile and Inflammation in Non-Alcoholic Fatty Liver Disease 125
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 124
Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum 123
Gut Microbiota Signatures Are Associated With Psychopathological Profiles in Patients With Ulcerative Colitis: Results From an Italian Tertiary IBD Center 122
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease 121
Gut microbiota and inflammatory bowel disease: an update 121
Functional hypothalamic amenorrhea: gut microbiota composition and the effects of exogenous estrogen administration 114
Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis 110
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 110
Impact of the Trophic Effects of the Secretome from a Multistrain Probiotic Preparation on the Intestinal Epithelia 109
Intestinal permeability in physiological and pathological conditions: major determinants and assessment modalities 108
Changes in the intestinal microbiota in patients with a major depressive episode and ulcerative colitis 107
Secretome modulation of Caco-2 cell line induced by a multi-strain probiotic 107
Infliximab does not increase colonic cancer risk associated to murine chronic colitis 104
Gut–joint axis: The role of physical exercise on gut microbiota modulation in older people with osteoarthritis 104
The gut–brain axis in irritable bowel syndrome and inflammatory bowel disease 104
null 102
Inflammatory Bowel Diseases and Sarcopenia: The Role of Inflammation and Gut Microbiota in the Development of Muscle Failure 101
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 98
Focus on Immune Checkpoint Inhibitors-related Intestinal Inflammation: From Pathogenesis to Therapeutical Approach 97
Evaluation of tolerability and major factors affecting the adherence to probiotic therapy in patients with irritable bowel syndrome: a prospective, observational, real-life study 94
The Key Nutrients in the Mediterranean Diet and Their Effects in Inflammatory Bowel Disease: A Narrative Review 92
Circular and Circulating DNA in Inflammatory Bowel Disease: From Pathogenesis to Potential Molecular Therapies 90
Extrachromosomal Circular DNA: An Emerging Potential Biomarker for Inflammatory Bowel Diseases? 90
Anti-TNF-α-induced psoriasiform lesions in IBD: An abnormal immune activation or a 'patchy cutaneous' immune suppression? 90
Bariatric procedures and microbiota: patient selection and outcome prediction 89
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 86
SECRETOME MODULATION OF CACO2 CELL LINE INDUCED BY A MULTI-STRAIN PROBIOTIC 85
Towards a disease-associated common trait of gut microbiota dysbiosis: The pivotal role of Akkermansia muciniphila 82
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone 78
The thrilling journey of sars-cov-2 into the intestine: From pathogenesis to future clinical implications 78
Intestinal inflammation and microbiota modulation impact cochlear function: emerging insights in gut-ear axis 76
IL-33 promotes recovery from acute colitis by inducing miR-320 to stimulate epithelial restitution and repair 76
Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis 75
Characterization of mucosal cytokine profile in ulcerative colitis patients under conventional and anti-TNF-a treatment 72
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 66
[Microbiota and inflammatory bowel disease: an update.] 64
ToF-SIMS and principal component analysis of lipids and amino acids from inflamed and dysplastic human colonic mucosa 61
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 36
Multistrain Probiotics Plus Vitamin D Improve Gut Barrier Function and Gut Microbiota Composition in Irritable Bowel Syndrome Without Constipation: Results from a Double-Blind, Randomized, Placebo-Controlled Trial 19
OCTN1 variants shape innate immunity and predict individual response to anti-TNFα in ulcerative colitis patients: An exploratory study 16
Establishment of Patient-Derived Organoids from Hepatocellular Carcinoma: Preliminary Data on Yield, Histopathological Concordance, and Methodological Challenges 9
The molecular basis of sarcopenia in inflammatory bowel disease: from gut-muscle axis to therapeutic opportunities 7
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study 6
Inflammatory bowel disease (IBD) is associated with increased intestinal extrachromosomal circular DNA: an emerging biomarker for IBD type and activity 4
Spectral analysis of blood components in diabetic patients with neuropathic complications: Exploring the diagnostic potential of extracellular vesicles 3
Clinical Predictive Factors for the Development of Short Bowel Syndrome in a Cohort of Patients with Crohn's Disease: A Prospective Study 3
MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer 2
Artificial Intelligence for Liquid Biopsy: FTIR Spectroscopy and Autoencoder-Based Detection of Cancer Biomarkers in Extracellular Vesicles 2
Totale 10.783
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.869
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.869
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022572 57 28 21 25 49 22 12 79 32 50 110 87
2022/20231.250 161 178 96 199 76 151 56 87 144 19 43 40
2023/2024780 46 176 29 43 32 101 49 27 43 34 85 115
2024/20251.646 42 45 136 54 143 69 86 71 225 177 321 277
2025/20264.460 627 119 262 570 808 234 667 221 308 341 154 149
2026/202783 83 0 0 0 0 0 0 0 0 0 0 0
Totale 10.783